Pfizer (PFE) Chief Executive Albert Bourla said the company's dispute with activist investor Starboard Value is over issues "on the margins" of its business and is not "an aggressive situation," Bloomberg reported Tuesday, citing lunchtime remarks with a group of reporters.

Bourla said Starboard has not demanded major changes such as cost cuts, board reshuffles, or a corporate breakup, the report cited Bourla as saying.

"I respect Starboard, and I try to be engaged with them," Bourla reportedly said. "If they have good ideas, we will do it."

Starboard did not immediately reply to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)